• 1
    Stoop AE, van der Heijden HA, Biewenga J, van der Baan S. Lymphocytes and nonlymphoid cells in human nasal polyps. J Allergy Clin Immunol 1991;87: 470475.
  • 2
    Stoop AE, van der Heijden HA, Biewenga J, van der Baan S. Clinical aspects and distribution of immunologically active cells in the nasal mucosa of patients with nasal polyps after endoscopic sinus surgery and treatment with topical corticosteroids. Eur Arch Otorhinolaryngol 1992;249: 313317.
  • 3
    Stoop AE, van der Heijden HA, Biewenga J, van der Baan S. Eosinophils in nasal polyps and nasal mucosa: an immunohistochemical study. J Allergy Clin Immunol 1993;91: 616622.
  • 4
    Morinaka S, Nakamura H. Inflammatory cells in nasal mucosa and nasal polyps. Auris Nasus Larynx 2000;27: 5964.
  • 5
    Fokkens WJ, Holm AF, Rijntjes E, Mulder PG, Vroom TM. Characterization and quantification of cellular infiltrates in nasal mucosa of patients with grass pollen allergy, non-allergic patients with nasal polyps and controls. Int Arch Allergy Appl Immunol 1990;93: 6672.
  • 6
    Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001;107: 607614.
  • 7
    Gevaert P, Bachert C, Holtappels G, Novo CP, van der Heyden J, Fransen L et al. Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis. Allergy 2003;58: 371379.
  • 8
    Rudack C, Stoll W, Bachert C. Cytokines in nasal polyposis, acute and chronic sinusitis. Am J Rhinol 1998;12: 383388.
  • 9
    Rolla G, Di Emanuele A, Dutto L, Marsico P, Nebiolo F, Corradi F et al. Effect of inhalation aspirin challenge on exhaled nitric oxide in patients with aspirin-inducible asthma. Allergy 2004;59: 827832.
  • 10
    Pawliczak R, Kowalski ML, Danilewicz M, Wągrowska-Danilewicz M, Lewandowski A. Distribution of mast cells and eosinophils in nasal polyps from atopic and nonatopic subjects: a morphometric study. Am J Rhinol 1997;11: 257262.
  • 11
    Pompen M, Smids BS, Dingemans KP, Jansen HM, Out TA, Lutter R. Lung epithelial H292 cells induce differentiation of immature human HMC-1 mast cells by interleukin-6 and stem cell factor. Clin Exp Allergy 2000;30: 11041112.
  • 12
    Saito H, Ebisawa M, Tachimoto H, Shichijo M, Fukagawaa K, Matsumoto K. Selective growth of human mast cells induced by steel factor, IL-6 and prostaglandin E2 from cord blood mononuclear cells. J Immunol 1996;157: 343350.
  • 13
    Nilsson G, Butterfield JH, Nilsson K, Siegbahn A. Stem cell factor is a chemotactic factor for human mast cells. J Immunol 1994;15: 37173723.
  • 14
    Olsson N, Ulfgren AK, Nilsson G. Demonstration of mast cell chemotactic activity in synovial fluid from rheumatoid patients. Ann Rheum Dis 2001;60: 187193.
  • 15
    Otsuka H, Kusumi T, Kanai S, Koyama M, Kuno Y, Takizawa R. Stem cell factor mRNA expression and production in human nasal epithelial cells: contribution to the accumulation of mast cells in the nasal epithelium of allergy. J Allergy Clin Immunol 1998;102: 757764.
  • 16
    Rosado A, Vives R, Gonzalez R, Rodriguez J. Can NSAIDs intolerance disappear? A study of three cases. Allergy 2003;58: 689690.
  • 17
    Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003;111: 913921.
  • 18
    Perez-Novo CA, Kowalski ML, Kuna P, Ptasińska A, Holtappels G, van Cauwenberge P et al. Aspirin sensitivity and IgE antibodies to Staphylococcus aureus enterotoxins in nasal polyposis: studies on the relationship. Int Arch Allergy Immunol 2004;133: 255260.
  • 19
    Kowalski ML, Grzegorczyk J, Pawliczak R, Kornatowski T, Wa˛growska-Danilewicz M, Danilewicz M. Decreased apoptosis and distinct profile of infiltrating cells in the nasal polyps in aspirin-sensitive patients Allergy 2002;57: 493500.
  • 20
    Hamilos DL, Leung DY, Wood R, Cunningham L, Bean OK, Yasruel Z et al. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol 1995;96: 537544.
  • 21
    Kim YK, Nakagawa N, Nakano K, Sulakvelidze I, Dolovich J, Denburg J. Stem cell factor in nasal polyposis and allergic rhinitis: increased expression by structural cells is suppressed by in vivo topical corticosteroids. J Allergy Clin Immunol 1997;100: 389399.
  • 22
    Dahlen B, Mellilo G. Inhalation challenge in ASA-induced asthma. Respir Med 1998;92: 378384.
  • 23
    Devalia JL, Sapsford RJ, Wells C, Richman P, Davies RJ. Culture and comparison of human bronchial and nasal epithelial cells in vitro. Respir Med 1990;84: 303312.
  • 24
    Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chlorophorm extraction. Anal Biochem 1987;162: 156159.
  • 25
    Labarca C, Paigen K. A simple, rapid and sensitive assay procedure. Anal Biochem 1980;104: 334352.
  • 26
    Weibel ER. Point counting methods. In: WeibelER, editor. Stereological methods, Vol. 1. London, New York, Toronto, Sydney, San Francisco: Academic Press, 1979: 101159.
  • 27
    Bischoff SC, Sellge G, Schwengberg S, Lorentz A, Manns MP. Stem cell factor-dependent survival, proliferation and enhanced releasability of purified mature mast cells isolated from human intestinal tissue. Int Arch Allergy Immunol 1999;118: 104107.
  • 28
    Undem BJ, Lichtenstein LM, Hubbard WC, Meeker S, Ellis JL. Recombinant stem cell factor-induced mast cell activation and smooth muscle contraction in human bronchi. Am J Respir Cell Mol Biol 1994;11: 646650.
  • 29
    Kowalski ML, Bieńkiewicz B, Kordek P, Pawliczak R. Nasal polyposis in aspirin-hypersensitive patients with asthma (aspirin triad) and aspirin-tolerant patients. Allergy Clin Immunol Int – World Allergy J 2003;6: 15.
  • 30
    Jankowski R. Immunohistological characteristics of nasal polyps. A comparison with healthy mucosa and chronic sinusitis. Rhinology 1986;8(Suppl. ):5158.
  • 31
    Picado C, Fernandez-Morata JC, Juan M, Roca-Ferrer J, Fuentes M, Xaubet A et al. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1999;160: 291296.
  • 32
    Kowalski ML, Pawliczak R, Wozniak J, Siuda K, Poniatowska M, Iwaszkiewicz J et al. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. J Respir Crit Care Med 2000;161: 391398.
  • 33
    Picado C, Bioque G, Roca-Ferrer J, Pujols L, Mullol J, Benitez P et al. Nuclear factor-kappa B activity is down-regulated in nasal polyps from aspirin-sensitive asthmatics. Allergy 2003;58: 122126.
  • 34
    Vignola AM, Bellia V. Transcriptional regulation of COX-2: a key mechanism in the pathogenesis of nasal polyposis in aspirin-sensitive asthmatics? Allergy 2003;58: 9597.
  • 35
    Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002;347: 14931499.
  • 36
    Lumry WR, Curd JG, Zeiger RS, Pleskow WW, Stevenson DD. Aspirin-sensitive rhinosinusitis: the clinical syndrome and effects of aspirin administration. J Allergy Clin Immunol 1983;71: 580587.
  • 37
    Szczeklik A. Aspirin-induced asthma as a viral disease. Clin Allergy 1988;18: 1520.
  • 38
    Kowalski ML. Rhinosinusitis and nasal polyposis in aspirin-sensitive and aspirin-tolerant patients: are they different? Thorax 2000;55(Suppl. 2):S84S86.